McKesson Corporation

MCK Healthcare Medical Distribution

McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025. In the quarter to June 2026, revenue grew 7.72%, EPS fell 17.7%, free cash flow grew 66.4% and total debt rose 10.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for ten.

1,006.92 8.28 +0.83%
Market cap
$116.4B
P/E
26.8×
Fwd P/E
18.3×
Dividend yield
0.34%
F-score
7/9
Altman Z
6.15
Beneish M
−2.34
Dividend safety
86/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
(168.45%) (274.39%) (240.78%) (201.80%)

+8 more TTM periods

Piotroski F-Score
7 7 7 7
ROA
5.41% 6.05% 5.59% 5.15%
ROIC
70.49% 66.20% 45.30% 43.80%
Return on Tangible Assets
(94.97%) (66.70%) (74.83%) (73.10%)
Average Days of Receivables
26.92 25.32 25.88 26.67
Free Cash Flow per Share
51.77 43.77 78.28 48.45
Free Cash Flow
6,145.00 5,410.00 9,644.00 6,008.00
Other line items

Show all line items

Columns are period end dates